| 纤溶酶原激活剂与抑制剂检测对恶性肿瘤诊断的临床价值 |
| |
| 引用本文： | 闫海润,金春明,仝连信,黄永存,姜蕾,金大伟,鞠传余.纤溶酶原激活剂与抑制剂检测对恶性肿瘤诊断的临床价值[J].牡丹江医学院学报,2011,32(4):36-38. |
| |
| 作者姓名： | 闫海润 金春明 仝连信 黄永存 姜蕾 金大伟 鞠传余 |
| |
| 作者单位： | 牡丹江医学院附属红旗医院检验科 黑龙江牡丹江 157011 |
| |
| 基金项目： | 黑龙江省教育厅科研项目 |
| |
| 摘 要： | 目的：探讨恶性肿瘤患者血液纤溶酶原激活剂与抑制剂检测的临床应用价值。方法：检测185例恶性肿瘤患者血液纤溶酶原激活剂（t—PA）、纤溶酶原抑制剂（PAI-1）活性变化，对检测数据进行统计学分析。结果：不同类型的恶性肿瘤患者与正常对照组t—PA及PAI-1比较差异有统计学意义（P〈0．05）。应用全自动血凝仪底物发光法检测恶性肿瘤患者纤溶活性变化具有敏感性、特异性、准确性高的优点。结论：检测t—PA及PAI-1活性变化，从而判断恶性肿瘤细胞侵润、增殖、转移及出血、血栓形成的原因。
|
| 关 键 词： | 纤溶酶原激活剂 纤溶酶原抑制剂 肿瘤 底物发光法 |
THE CLINICAL VALUE OF DETECTING BLOOD PLASMINOGEN ACTIVATOR AND INHIBITOR IN CANCER PATIENTS |
| |
| Institution: | Yan Hai-run et al (Department of Clinical Laboratory,Hongqi Hospital of Mudanjiang City,Mudanijiang 157011,China) |
| |
| Abstract: | Objective：To discuss the clinical value of detecting blood plasminogen activator and inhibitor in cancer patients. Methods：Activity of blood plasminogen activator and inhibitor was detected in 185 cases cancer patients, and the date were statistically analyed. Results： There were significant differences in t - PA and PAI- 1 levels between the normal group and different types of cancer patients （ p 〈 0.05 ）. The sensitivity, specificity and accuracy of fibrinolytic activity detected with the automated blood analyzer chemiluminescence substrate were higher than those of routine test. Conclusion ：The detecting of activity of t - PA and PAI- 1 contributes to determine the reasons for the invasion of malignant cells , Proliferation , metastasis and the bleeding, thrombosis. |
| |
| Keywords: | Plasminogen activator Plasminogen inhibitor Cancer Luminescence substrate |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
